Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_assertion type Assertion NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_head.
- NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_assertion description "[While ARLTS1 Trp149Stop did not influence melanoma risk (OR = 0.83, 95% CI = 0.37-1.88, p = 0.65), Cys148Arg revealed a statistically significant association with an increased risk for heterozygous carriers (OR = 1.43, 95% CI = 1.05-1.95, p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_provenance.
- NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_assertion evidence source_evidence_literature NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_provenance.
- NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_assertion SIO_000772 16646072 NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_provenance.
- NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_assertion wasDerivedFrom befree-20140225 NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_provenance.
- NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_assertion wasGeneratedBy ECO_0000203 NP878159.RAoWT4FdvY2vM3opdAnkhlp5OYLTANbKTs-_z4xP1Q0Vg130_provenance.